| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUR.1985.04060050066010 |
| P698 | PubMed publication ID | 3994563 |
| P50 | author | David J. Greenblatt | Q88911712 |
| Darrell Abernethy | Q18977896 | ||
| P433 | issue | 5 | |
| P921 | main subject | obesity | Q12174 |
| phenytoin | Q410400 | ||
| P304 | page(s) | 468-471 | |
| P577 | publication date | 1985-05-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Phenytoin disposition in obesity. Determination of loading dose | |
| P478 | volume | 42 |
| Q72281596 | Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism |
| Q34075909 | Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance |
| Q46169405 | Body mass index and weight gain as alternative or complementary hypothesis to explain olanzapine concentration-dose ratio accumulation |
| Q90285984 | Critical Care Management of Status Epilepticus at a Tertiary Care University Hospital |
| Q35587926 | Dosing of medications in morbidly obese patients in the intensive care unit setting |
| Q37940887 | Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation |
| Q37672600 | Effect of obesity on the pharmacokinetics of drugs in humans |
| Q34053786 | Effects of obesity on pharmacokinetics implications for drug therapy |
| Q54959708 | IV fosphenytoin in obese patients: Dosing strategies, safety, and efficacy. |
| Q41699431 | Impact of a phenytoin loading dose program in the emergency department |
| Q37997025 | Impact of obesity on drug metabolism and elimination in adults and children |
| Q68324052 | Intravenous phenytoin loading in patients after neurosurgery and in status epilepticus. A population pharmacokinetic study |
| Q34162361 | Management of the obese critically ill patient |
| Q68329026 | Metronidazole Impairs Clearance of Phenytoin but Not of Alprazolam or Lorazepam |
| Q92799285 | Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly |
| Q77752248 | Pharmacokinetic considerations in obesity |
| Q34476850 | Pharmacokinetics and drug dosing in obese children |
| Q33855312 | Pharmacokinetics of Antimicrobials in Obese Children |
| Q73321098 | Pharmacokinetics of quinine in obesity |
| Q68126839 | Phenobarbital pharmacokinetics in obesity. A case report |
| Q35629713 | Resuscitation of the morbidly obese patient |
| Q73204272 | Single oral loading dose of phenytoin: a pharmacokinetics study |
| Q36111191 | Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology |
| Q42281128 | Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes. |
| Q35826324 | What is the best size descriptor to use for pharmacokinetic studies in the obese? |
Search more.